BICO Group AB
STO:BICO

Watchlist Manager
BICO Group AB Logo
BICO Group AB
STO:BICO
Watchlist
Price: 18.74 SEK -0.95% Market Closed
Market Cap: 1.3B SEK

BICO Group AB
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

BICO Group AB
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
BICO Group AB
STO:BICO
Cash from Operating Activities
kr158.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Cash from Operating Activities
kr1.1B
CAGR 3-Years
3%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cash from Operating Activities
kr348m
CAGR 3-Years
1%
CAGR 5-Years
6%
CAGR 10-Years
14%
G
Genovis AB
STO:GENO
Cash from Operating Activities
kr34.7m
CAGR 3-Years
-7%
CAGR 5-Years
38%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Cash from Operating Activities
kr317.6m
CAGR 3-Years
24%
CAGR 5-Years
29%
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash from Operating Activities
-kr11.7m
CAGR 3-Years
N/A
CAGR 5-Years
-11%
CAGR 10-Years
N/A
No Stocks Found

BICO Group AB
Glance View

BICO Group AB is a bioconvergence company, which engages in the provision of technologies, products, and services to create, understand and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 890 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

BICO Intrinsic Value
HIDDEN
Show

See Also

What is BICO Group AB's Cash from Operating Activities?
Cash from Operating Activities
158.4m SEK

Based on the financial report for Dec 31, 2024, BICO Group AB's Cash from Operating Activities amounts to 158.4m SEK.

What is BICO Group AB's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
-11%

Over the last year, the Cash from Operating Activities growth was -11%.

Back to Top